Watchmaker Genomics · 2 hours ago
Quality Control (QC) Analyst
Watchmaker Genomics is inviting applications for the full-time position of Quality Control Analyst, focusing on Molecular Biology/Biochemistry. The role involves executing core QC processes, developing and validating new assays, and collaborating with cross-functional teams to address product quality issues.
BiotechnologyHealth CareMedical
Responsibilities
Execution, documentation, and analysis of routine QC processes
Independent evaluation and interpretation of data from various assays
Assay development and validation
Participation in cross-functional teams to resolve product quality issues, corrective actions, investigations, and develop/implement in-process improvements
Qualification
Required
At least 3 years of relevant laboratory experience in biochemistry, molecular biology, or a related discipline
Creative and disciplined problem solving skills
Excellent organizational skills and superior attention to detail
The ability to multitask, work at a high standard, perform consistently under pressure along with pre-determined deadlines and work without supervision
Strong interpersonal skills and an ability to work as an effective member of a team
Excellent communication, personal task management skills and high levels of motivation and initiative
A creative and disciplined approach to problem-solving
Preferred
2+ years Quality Control/Manufacturing/Quality Assurance experience
Experience in biotech and a start-up environment
Gel electrophoresis
PCR, qPCR
Next-generation sequencing (NGS)
Enzyme activity assays
Manufacturing in a controlled environment
ISO 13485
Quality Management Systems
Good Laboratory Practice
Benefits
Flexible Time Off
Holidays
Employer covers 75% of base medical plan with buy-up options
EAP (employee assistance program)
Employer paid dental
Employer paid vision
Employer paid $25,000 life/AD&D policy
Paid parental leave
401(k) retirement plan with a 4% match
Company
Watchmaker Genomics
Watchmaker Genomics is a biotechnology company that focuses on breakthrough applications for reading, writing, and editing DNA.
Funding
Current Stage
Growth StageTotal Funding
$48.27MKey Investors
Decheng Capital
2022-06-02Series A· $40M
2020-08-27Series Unknown· $8.27M
Recent News
2025-12-15
2025-11-14
Company data provided by crunchbase